Literature DB >> 9489645

The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.

G Kögler1, J Callejas, R V Sorg, J Fischer, A R Migliaccio, P Wernet.   

Abstract

Assuming a threshold of 2 x 10(7) nucleated cells (NC)/kg body weight required for transplantation and 10 +/- 5 x 10(8) NC per cord blood (CB) unit (n = 1828, July 1997), 100%, 65% and 25% of the CB units stored in the CB Bank Düsseldorf contain sufficient NC to engraft patients of 10 kg, 35 kg and 50-70 kg, respectively. Thus, there is a potential limitation for the use of CB in adults which, however, may be overcome by ex vivo expansion of cells important in the different phases of engraftment. Therefore, four combinations of SCF, Flt3-L, IL-3, erythropoietin and GM-CSF as well as three media were evaluated for their capacity to amplify hematopoietic progenitors. A prerequisite for expansion was the significantly higher recovery of CD34+ cells, colony-forming cells (CFC) and long-term culture-initiating cells (LTC-IC) by thawing cryopreserved CB units with an isotonic albumin/dextran solution. When CD34+ CB cells were cultured with the four cytokine combinations in H5100 medium, all combinations promoted an expansion of total cells (43 to 356-fold) and CFC (49 to 462-fold) within 7 days, however, early progenitors as defined by mixed-colony formation (CFU-GEMM) were substantially amplified only with SCF, Flt3-L plus IL-3 (94.3 +/- 62.4-fold). H5100 medium or a serum-free medium supplemented with SCF, Flt3-L plus IL-3 were superior to 20% FCS/RPMI-1640 medium in the expansion of all progenitor cell types and were similarly effective in supporting the amplification of total cells, CFC, CFU-GM, BFU-E/CFU-E and LTC-IC (maximum at day 7: 6.7 +/- 3.4-fold and 5.5 +/- 0.5-fold, respectively). However, the serum-free medium promoted a significantly higher expansion of CFU-GEMM (176.9 +/- 81.7-fold) than H5100 medium (83.5 +/- 26.2-fold) at day 7 and only under serum-free conditions, CFU-GEMM were maintained over 14 days in tissue culture. These results demonstrate that committed progenitors as well as the more immature CFU-GEMM and LTC-IC can be substantially amplified at the same time without exhausting the proliferative potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489645     DOI: 10.1038/sj.bmt.1701088

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

1.  Ex vivo expansion of human umbilical cord blood CD34+ cells in a collagen bead-containing 3-dimensional culture system.

Authors:  Han-Soo Kim; Jong Baeck Lim; Yoo Hong Min; Seung Tae Lee; Chuhl Joo Lyu; Eun Seok Kim; Hyun Ok Kim
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

2.  Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.

Authors:  P Meissner; B Schröder; C Herfurth; M Biselli
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

Review 3.  Concise review: umbilical cord blood transplantation: past, present, and future.

Authors:  Javier Munoz; Nina Shah; Katayoun Rezvani; Chitra Hosing; Catherine M Bollard; Betul Oran; Amanda Olson; Uday Popat; Jeffrey Molldrem; Ian K McNiece; Elizabeth J Shpall
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

4.  A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.

Authors:  Gesine Kögler; Sandra Sensken; Judith A Airey; Thorsten Trapp; Markus Müschen; Niklas Feldhahn; Stefanie Liedtke; Rüdiger V Sorg; Johannes Fischer; Claudia Rosenbaum; Susanne Greschat; Andreas Knipper; Jörg Bender; Ozer Degistirici; Jizong Gao; Arnold I Caplan; Evan J Colletti; Graça Almeida-Porada; Hans W Müller; Esmail Zanjani; Peter Wernet
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

5.  Quality of cord blood cryopreserved for up to 5 years.

Authors:  Hye Ryun Lee; Eun Young Song; Sue Shin; Eun Youn Roh; Jong Hyun Yoon; Byoung Jae Kim
Journal:  Blood Res       Date:  2014-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.